Loading...
NPI 1831373067 · Orangeburg, SC · Durable Medical Equipment & Medical Supplies
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Orange Cut Rate Drug Store, Inc. is a durable medical equipment & medical supplies provider located in Orangeburg, South Carolina. This profile covers 12 Medicare and 36 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Orange Cut Rate Drug Store, Inc. |
| Address | 1324 Grove Park Ne |
| City | Orangeburg |
| State | SC |
| ZIP | 29115 |
| Taxonomy | Durable Medical Equipment & Medical Supplies |
| NPI Enumerated | December 24, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $3.7M |
| Medicare | $222.8K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
12 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 90662 | This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection… | 980 | $70 | $70.8K |
| 91304 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to prevent the patient from contracting COVID–19. The dosage is 5 mcg/0.5 mL. | 230 | $150 | $32.8K |
| G0008 | Administration of influenza virus vaccine | 1,030 | $30 | $29.7K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 210 | $130 | $27.1K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 540 | $40 | $21K |
| 90677 | This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the… | 60 | $280 | $17.2K |
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 100 | $140 | $14.4K |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 300 | $10 | $3.6K |
| 0134A | N/A | 80 | $40 | $3.1K |
| G0009 | Administration of pneumococcal vaccine | 60 | $30 | $1.8K |
Showing 1–10 of 12
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 12 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
12 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 91322 | 234 | 550 | 90 | $140 | $17K |
| 91320 | 67 | 500 | 50 | $130 | $12.7K |
| K1034 | 357 | 550 | 430 | $10 | $9K |
| 90677 | 96 | 1,230 | 20 | $280 | $8.9K |
| 90662 | 1 | 1,370 | 50 | $70 | $5.5K |
| 90480 | 13 | 880 | 100 | $30 | $4.5K |
| 91304 | 1 | 20 | 20 | $140 | $4K |
| G0008 | 7 | 2,330 | 60 | $30 | $3.1K |
| 0124A | 188 | 330 | 20 | $40 | $1.3K |
| 0134A | 21 | 340 | 20 | $40 | $1.3K |
Showing 1–10 of 12
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
36 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| A4554 | Disposable underpads, all sizes | 18,360 | $30 | $605.7K |
| T4528 | Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each | 5,260 | $70 | $367.9K |
| X1939 | N/A | 5,410 | $60 | $335.7K |
| T4543 | Adult sized disposable incontinence product, protective brief/diaper, above extra large, each | 2,070 | $130 | $274.6K |
| T4527 | Adult sized disposable incontinence product, protective underwear/pull-on, large size, each | 4,990 | $50 | $264.6K |
| T4526 | Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each | 4,940 | $50 | $236.9K |
| T5999 | Supply, not otherwise specified | 28,590 | $10 | $228.7K |
| T4524 | Adult sized disposable incontinence product, brief/diaper, extra large, each | 2,010 | $100 | $209.1K |
| E1390 | Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate | 2,880 | $60 | $184.1K |
| T2028 | Specialized supply, not otherwise specified, waiver | 1,280 | $90 | $114.2K |
Showing 1–10 of 36
How this provider's Medicaid billing volume and revenue compare to other South Carolina providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. South Carolina median
36 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| E1390 | Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate | 51 | 90 | 4,560 | $50 | $268.2K |
| A4554 | Disposable underpads, all sizes | 14 | 110 | 2,350 | $30 | $207.9K |
| T4543 | Adult sized disposable incontinence product, protective brief/diaper, above extra large, each | 9 | 40 | 840 | $130 | $193.5K |
| X1939 | N/A | 9 | 70 | 1,410 | $60 | $179.9K |
| T2028 | Specialized supply, not otherwise specified, waiver | 11 | 30 | 760 | $110 | $150K |
| A4253 | Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips | 4 | 10 | 370 | $70 | $147.9K |
| T4528 | Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each | 11 | 70 | 1,160 | $70 | $143.6K |
| T4527 | Adult sized disposable incontinence product, protective underwear/pull-on, large size, each | 13 | 80 | 1,260 | $50 | $130.8K |
| T4526 | Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each | 9 | 70 | 1,020 | $50 | $109K |
| T5999 | Supply, not otherwise specified | 16 | 120 | 3,700 | $10 | $103.8K |
Showing 1–10 of 36
Other providers in the same ZIP code as Orange Cut Rate Drug Store, Inc., ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Orangeburg Co. Dsn Board | SC | Public Health or Welfare Agency | $0 | $29.6M |
| Family Health Centers, Inc | SC | Federally Qualified Health Center (FQHC) | $0 | $12M |
| The Pediatric Clinic, P.A. | SC | Pediatrics Physician | $0 | $5M |
| Kool Smiles Sc-2, PC | SC | General Practice Dentistry | $0 | $3M |
| Audrey Gordon | SC | Pediatric Dentistry | $0 | $2.4M |
| Guardian Angels Medical Transportation LLC | SC | Ambulance | $384.8K | $0 |
| Sabina Abbasova | SC | Foot & Ankle Surgery Podiatrist | $207K | $0 |
| Fantasia Chandler | SC | Family Nurse Practitioner | $151.8K | $0 |
| Willie Louis | SC | Family Medicine Physician | $108.4K | $0 |
| Gregory Singleton | SC | Family Medicine Physician | $86.9K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.